Skip to content

Reported May 5, 2026 · After market close

Revenue estimate$14.9M
EPS estimate-$0.43

Next report

Jul 21, 2026 (In 3 weeks)
Revenue estimate$18.0M
EPS estimate-$0.43

Financials

Q1 2026

Income statement

See full
Revenue$16.1M+58.2%
Gross profit$12.4M+62.7%
Operating income-$9.3M-62.2%
Net income-$8.7M-51.8%
EPS (diluted)-$0.32+78.2%

Balance sheet

See full
Cash & equivalents$73.0M+68.1%
Total debt$17.3M
Total equity$92.2M+220%
Total assets$118.8M

Cash flow

See full
Operating cash flow-$13.0M-59.5%
CapEx$79.0K-4.8%
Free cash flow-$13.1M-58.8%

Valuation & ratios

Valuation

as of 06/26/26
See full
Market cap$305.56M
Enterprise value$249.8M
P/S5.4×

Profitability

See full
Gross margin75.9%+1.4pp
Operating margin-60.5%-10.2pp
Net margin-57.8%-11.2pp
FCF margin-61.1%

Returns & leverage

See full
Debt / equity0.2×
Current ratio11.9×

Versus estimates

Ask the moment Carlsmed, Inc. Common Stock reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Carlsmed, Inc. Common Stock report Q1 2026 earnings?
Carlsmed, Inc. Common Stock (CARL) reported Q1 2026 earnings on May 5, 2026 after market close.
What were Carlsmed, Inc. Common Stock's Q1 2026 revenue and EPS?
Carlsmed, Inc. Common Stock reported revenue of $16.1M and diluted EPS of $-0.32 for Q1 2026.
Did Carlsmed, Inc. Common Stock beat estimates in Q1 2026?
Revenue beat the consensus estimate of $14.9M by $1.2M. EPS beat the consensus estimate of $-0.43 by $0.11.
Where can I find Carlsmed, Inc. Common Stock's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001794546-26-000010) and the 10-Q periodic report (0001794546-26-000011) directly on SEC EDGAR. The filing index links above go to sec.gov.